baber/WOPTO huggingface dataset:
Patent NZ-538327-A (NZ)
Title: New process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
Inventor: LERESTIF JEAN-MICHEL
IPC: C07D223/16
Filed: 2005-02-18
Abstract: A process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds of formula (I) is disclosed, wherein a compound of formula (IV) is subjected to an alkylation reaction using the compound of formula (V), in an organic or hydro-organic solvent, in the presence of a base selected from sodium hydroxide, potassium hydroxide, ammonia in aqueous solution, carbonates and bicarbonates, to yield, after isolation, the compound of formula (I). The substituents for the variables shown in formulae (I), (IV) & (V) are as defined in the specification. These compounds of formula (I) are useful as intermediate compounds in the synthesis of ivabradine.
Patent NZ-539348-A (NZ)
Title: Improvements in or relating to a rack for drinking vessels
Inventor: PARKER PHILIP ANTHONY
Filed: 2005-04-08
Abstract: A rack to in use hold two or more drinking vessels, the rack comprising a rack body and a releasable locking portion, the rack body including a first locating means to, in use, locate against a first sector of the base of each said drinking vessel, a second locating means to, in use locate against a portion of each said drinking vessel upstanding from the said vessel base, and capture means to releasably capture the releasable locking portion, the releasable locking portion including first engagement means to engage with a second sector of each said vessel base such that once in position each said vessel is prevented from moving in two perpendicular directions as a consequence of interaction between the vessel base, the second engagement means of the releasable locking portion, and the first locating means of the rack body and is prevented from moving in a third perpendicular direction as a consequence of interaction between the second locating means of the rack body and the upstanding portion of the said vessel.
Patent NZ-540312-A (NZ)
Title: Drive for a lift installation
Inventor: FISCHER DANIEL
IPC: B66B11/04
Filed: 2005-05-24
Abstract: A drive for a lift installation which drives a cage and a counterweight by way of supporting and driving means. The dive means comprises a drive shaft and a drive pulley and a brake is arranged at the left or the right of the drive pulley or at an end of the motor. The torque transmission from the brake to the support or to the motor or to the next brake takes place by means of pins.
Patent NZ-545697-A (NZ)
Title: A lambda-intR mutein comprising a glutamic acid to arginine change at position 174 of Wt lambda-intR
Inventor: PERKINS EDWARD
IPC: C12Q1/68
Filed: 2002-05-30
Abstract: A lambda-intR mutein comprising a glutamic acid to arginine change at position 174 of wild-type lambda-intR. The lambda-intR can comprise the SEQ IDNO 37, an amino acid signal for nuclear localisation, or an epitope tag for protein purification.
Patent NZ-545829-A (NZ)
Title: Multifunctional material having carbon-doped titanium oxide layer
Inventor: FURUYA MASAHIRO
IPC: C23C8/02
Filed: 2004-12-08
Abstract: The disclosure relates to a multifunctional material characterized by having at least a surface layer comprising a carbon-doped titanium oxide layer, and having the carbon doped in a state of Ti-C bonds, wherein the carbon-doped titanium oxide layer contains 0.3 to 15 at% of carbon. Also disclosed is a visible light responding photocatalyst containing said multifunctional material.
Patent NZ-553353-A (NZ)
Title: LDPC decoding methods and apparatus
Inventor: RICHARDSON TOM
IPC: H03M13/11
Filed: 2005-07-20
Abstract: An low density parity checker (LDPC) decoder, comprises a message source including a message output for supplying N messages in parallel; a node processing module including N node processors arranged in parallel; a controllable permutator coupling the message source to the node processing module; a control module for generating a first address control signal as a function of stored code description information and a block selection module for generating a block address selection signal. N is greater than 1. The controllable permutator includes a re-ordering control signal input for receiving a reordering control signal used to control reordering messages, in at least one set of N messages, being passed through the controllable permutator. The control module has a first address control signal output coupled to the message source and the block selection module has a block address selection signal output coupled to the message source.
Patent NZ-556188-A (NZ)
Title: New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: YOUS SAID
Filed: 2007-06-28
Abstract: N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propanamide of formula (I), its enantiomers, and addition salts thereof with a pharmaceutically acceptable base are disclosed. These compounds are suitable for treating disorders of the melatoninergic system, wherein the disorder is selected form sleep disorders, stress, anxiety, major depression or seasonal affective disorder, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue due to jetlag, schizophrenia, panic attacks, melancholia, appetite disorders, obesity, insomnia, psychotic disorders, epilepsy, diabetes, Parkinson's disease, senile dementia, various disorders associated with normal or pathological aging, migraine, memory loss, Alzheimer's disease, cerebral circulation disorders or sexual dysfunctions, as ovulation-inhibitors or immunomodulators, or for the treatment of cancers.
Patent NZ-556216-A (NZ)
Title: Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm using binodenoson
Inventor: BARRETT RICHARD J
IPC: A61B5/00
Filed: 2006-01-12
Abstract: Binodenoson can be used to manufacture a medicament for diagnosing myocardial dysfunction, perfusion abnormalities, the presence and severity of coronary artery disease, or ventricular dysfunction caused by coronary artery disease, in a human patient having a history of asthma or bronchospasm, wherein the medicament is formulated for administration by an intravenous route to the human patient of about 0.1 to about 10 microg/kg of binodenoson, foIlowed by detecting myocardial dysfunction, perfusion abnormalities, coronary artery disease or ventricular dysfunction in the human patient.
Patent NZ-561751-A (NZ)
Title: Skate and skateboard steering unit
Inventor: NELSON LARRY
Filed: 2007-09-20
Abstract: A device to provide a steering action and suspension to skating vehicles, such as a skateboard, is disclosed. The device includes a resilient mounting block (7) that supports a beam (6), and an axle mounted on the beam, with wheels supported at the ends of the axle. The device further has a number of pivoting rod-shaped members (1) that affect some degree of rotation of the beam and axle in a horizontal plane whenever the skateboard is tilted from side-to-side. Pivot mounting brackets (3) for the rod-shaped members are capable of being fixed in a range of positions to enable steering ratio adjustment by varying the non-deflected static angle of the rod-shaped members.
Patent NZ-562712-A (NZ)
Title: Gaming apparatus and systems
Inventor: ELLIS BENJAMIN JAMES
IPC: G07F17/32
Filed: 2004-06-23
Abstract: A gaming system includes three or more roulette wheels; input means for allowing a user to place a bet or bets on the three or more roulette wheels during a round of betting; means for determining the win statuses of the three or more roulette wheels after a round of spins; and means for displaying the bet outcome, the bet outcome being based on the input bet or bets and on the win statuses of the roulette wheels. The wheels can be virtual and/or physical wheels.
Patent NZ-566979-A (NZ)
Title: Animal portal with coil wound around and horizontal radiator elements to each side
Inventor: GUNSTON PATRICK BERNARD
IPC: H01Q11/12
Filed: 2006-09-19
Abstract: Disclosed is portal antenna, particularly suited for enabling low frequency RFlD devices carried by animals to be read when the animals pass through a stock race. The antenna includes a portal structure (10) through which an animal can pass and about which is wound at least one coil (18/19) of antenna conductor. At least one elongate radiator element (21) projects to at least one side of the portal structure, and has a longitudinal axis that is at an angle of less than 90° to a plane in which the antenna coil lies.
Patent NZ-571047-A (NZ)
Title: Medicament formulations comprising pradofloxacin
Inventor: HEEP IRIS
IPC: A61K31/496
Filed: 2007-02-23
Abstract: Disclosed is a liquid composition containing pradofloxacin and an antioxidative sulphur compound such as a sulphite. Also disclosed is the use of the composition for controlling bacterial diseases.
Patent NZ-571372-A (NZ)
Title: A fluid-tight slide fastener
Inventor: COSSUTTI LIVIO
IPC: B32B3/00
Filed: 2008-09-19
Abstract: A fluid-tight slide fastener and an associated process of manufacture is disclosed. The fluid-tight slide fastener including a pair of tapes (12), each of the tapes having an inner textile layer and a fluid barrier layer enveloping the textile layer, and a number of engaging teeth elements (21) provided on a side portion of the tapes. The inner textile layer of tapes is made with a spun yarn of cut fibers which are obtained by cutting a continuous fiber of synthetic textile material into smaller lengths. The spun yarn of cut fibers has surface irregularities which remain embedded in the fluid barrier layer.
Patent NZ-574551-A (NZ)
Title: Use of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol (T-817) and it derivatives for the treatment of conditions such as cancer, tumour and glucose metabolism
Inventor: FUKUSHIMA TETSUO
IPC: C07D409/12
Filed: 2007-08-02
Abstract: Disclosed is the use of 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol and its derivatives for the manufacture of a medicament for enhancing protein kinase C activity, and particularly for the treatment of neoplastic diseases such as tumors, and glucose metabolism disorders.
Patent NZ-576583-A (NZ)
Title: Freeze-dried pharmaceutical composition comprising vinfluine or vinorelbine and a carbohydrate which is stable at room temperature
Inventor: LEVERD ELIE
IPC: A61K31/475
Filed: 2007-12-28
Abstract: Disclosed is a pharmaceutical compositions comprising a hydrosoluble salt of vinflunine or vinorelbine, stable at room temperature, wherein said hydrosoluble salt of vinflunine or vinorelbine is in a freeze-dried form obtained in the presence of at least one carbohydrate.
Patent NZ-581460-A (NZ)
Title: Polymer conjugates of mutated neublastin
Inventor: SAH DINAH WEN-YEE
IPC: A61K6/00
Filed: 2004-02-02
Abstract: Provided is a dimer comprising a first neublastin polypeptide and a second neublastin polypeptide, wherein (a) at least one of the polypeptides is glycosylated, and (b) at least one of the polypeptides is conjugated at its N-terminus to a water-soluble synthetic polymer, which can be polyethylene glycol (PEG). (62) Divided Out of 541921
Patent NZ-586058-A (NZ)
Title: Benzomorphan compounds
Inventor: KYLE DONALD J
IPC: A61K31/14
Filed: 2008-11-28
Abstract: 586058 Disclosed are benzomorphan compounds as represented by the general Formula I, wherein R1 and R2 are each independently selected from the group consisting of alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, -(CH2)n-O-(CH2)n-CH3, alkoxy, C(halo)3, CH(halo)2, CH2(halo), C(O)R6, -C(O)O-alkyl, and -(CH2)n-N(R7)2, each of which is optionally substituted by 1, 2, or 3 independently selected R8 groups; wherein at least one of R1 and R2 is alkyl which is substituted by one R8 group, wherein the R8 group is selected from cycloalkyl; R3 and R4 are each independently selected from H, alkyl, alkenyl, and alkynyl; R5 is selected from (a) H, OH, halo, C(halo)3, -CH(halo)2, and -CH2(halo); or (b) alkyl, alkenyl, alkynyl, -(CH2)n-O-(CH2)n-CH3, alkoxy, each of which is optionally substituted with 1, 2, or 3 independently selected R8 groups; R6 is selected from -H, alkyl, alkenyl, alkynyl, and alkoxy; each R7 is independently selected from H, alkyl, alkenyl, and alkynyl; each R8 is independently selected from OH, halo, alkyl, alkenyl, alkynyl, alkoxy, cycloalkyl , -CHO, CO2H, -C(halo)3, -CH(halo)2, CH2(halo), and -(CH2)n-O-(CH2)n-CH3; X- is an organic or inorganic anion; each n is independently selected from an integer from 0, 1, 2, 3, 4, 5, or 6 or a solvate or prodrug thereof, wherein the prodrugs are esters of compounds of formula (I). A representative compound includes 2'-hydroxy-2,5,9-trimethyl-2-cyclopropylmethyl-6,7-benzomorphanium-iodide / 3-cyclopropylmethyl-1,2,3,4,5,6-hexahydro-8-hydroxy-3,6,11-trimethyl-2,6-methano-3-benzazocinium iodide. Further disclosed is the use of a compound of Formula I as defined above for the manufacture of a pharmaceutical composition for the treatment of constipation.
Patent NZ-587230-A (NZ)
Title: Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
Inventor: BOONE THOMAS C
IPC: A61K39/395
Filed: 2009-02-20
Abstract: Disclosed is an isolated monoclonal antibody which comprises a heavy chain variable domain and a light chain variable domain, wherein said heavy chain comprises 3 CDRs and said light chain comprises 3 CDRs, wherein the sequences of said CDRs of said antibody are selected from the group consisting of: (a) SEQ ID NOs: 18, 26, 32 of the HC plus SEQ ID NOs: 19, 27, 33 of the LC, (b) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 19, 27, 33 of the LC, (c) SEQ ID NOs: 18, 26, 35 of the HC plus SEQ ID NOs: 20, 27, 36 of the LC, (d) SEQ ID NOs: 18, 26, 37 of the HC plus SEQ ID NOs: 19, 27, 33 of the LC, (e) SEQ ID NOs: 18, 26, 38 of the HC plus SEQ ID NOs: 19, 27, 33 of the LC, (f) SEQ ID NOs: 18, 26, 35 of the HC plus SEQ ID NOs: 19, 27, 33 of the LC, (g) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 21, 27, 33 of the LC, (h) SEQ ID NOs: 18, 28, 39 of the HC plus SEQ ID NOs: 19, 27, 33 of the LC, (i) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 22, 27, 33 of the LC, (j) SEQ ID NOs: 18, 26, 32 of the HC plus SEQ ID NOs: 22, 27, 33 of the LC, (k) SEQ ID NOs: 18, 29, 39 of the HC plus SEQ ID NOs: 19, 27, 33 of the LC, (l) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 23, 27, 33 of the LC, (m) SEQ ID NOs: 18, 26, 35 of the HC plus SEQ ID NOs: 20, 27, 40 of the LC, (n) SEQ ID NOs: 18, 26, 32 of the HC plus SEQ ID NOs: 21, 27, 33 of the LC, (o) SEQ ID NOs: 18, 26, 35 of the HC plus SEQ ID NOs: 24, 27, 33 of the LC, (p) SEQ ID NOs: 18, 26, 35 of the HC plus SEQ ID NOs: 21, 27, 33 of the LC, (q) SEQ ID NOs: 18, 26, 35 of the HC plus SEQ ID NOs: 23, 27, 33 of the LC, (r) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 20, 30, 33 of the LC, (s) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 25, 27, 33 of the LC, (t) SEQ ID NOs: 18, 26, 35 of the HC plus SEQ ID NOs: 20, 30, 33 of the LC, (u) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 20, 27, 40 of the LC, and (v) SEQ ID NOs: 18, 26, 34 of the HC plus SEQ ID NOs: 20, 31, 33 of the LC; wherein said antibody specifically binds to at least one of Ang1 and Ang2 ligands of Tie 2 receptor.
Patent NZ-591549-A (NZ)
Title: A wave electrical power plant with a float connected by a cable to a linear generator via a parabolic curved circular wire guide, the cable moves through a seal to maintain watertightness
Inventor: STROMSTEDT ERLAND
IPC: F16J15/18
Filed: 2008-08-26
Abstract: Disclosed is an ocean or water wave-power unit for the production of electric energy. The wave-power unit comprises a floating body arranged for floating on the sea surface and an electric linear generator having a stator and a translator reciprocating along a centre axis. The stator is anchored in the bed of a sea and the translator being connected to the floating body by connection means such as a cable or wire rope or rod. The wave-power unit includes a water-tight encapsulation enclosing the generator and having an upper end wall with an opening through which the connection means extends, the opening being provided with a resilient seal that seals against the connection means, the seal being flexibly mounted so that it allows lateral and angular movements of the seal. The seal is supported by a supporting element that is mounted on said upper end wall via a flexible member, the flexible member being connected to said supporting element and to said upper end wall in a water-tight arrangement.
Patent NZ-593781-A (NZ)
Title: Polyunsaturated fatty acid and diol ester as an anti-acne agent
Inventor: REDOULES DANIEL
IPC: C07C69/587
Filed: 2009-12-21
Abstract: Disclosed are compounds of formula (I) (esters of an alkanediol and a polyunsaturated fatty acid), wherein n is an integer between 1 and 15, m is 0, 1, 2, or 3, and R is the hydrocarbon chain of a polyunsaturated fatty acid selected from omega-3 and omega-6. Further disclosed is a pharmaceutical or cosmetic composition comprising a compound of formula (I), the use of a compound of formula (I) in the preparation of a pharmaceutical or cosmetic composition for the treatment of acne or seborrheic dermatitis, and a method for preparing a compound of formula (I) by coupling a polyunsaturated fatty acid selected from omega-3 and omega-6 fatty acids, whose carboxylic acid function is in free or activated form, and a diol.
Patent NZ-595064-A (NZ)
Title: Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
Inventor: GERLACH MATTHIAS
IPC: A61K31/498
Filed: 2010-03-25
Abstract: 595064 Disclosed herein is a quinoxaline derivative of formula I, wherein the variables are defined in the specification, a pharmaceutical composition and medicament comprising said compound, and the use of said compound in the treatment of tumour disorders such as active compound-resistant tumour disorders and metastasic carinomas. Embodiments of the compound include the following: 1-[7-(4-hydroxy-3-methoxyphenyl)quinoxalin-2-yl]-3-[1-(2,2,2-trifluoroacetyl)piperidin-4-yl]urea, 1-cyclopropyl-3-[7-(4-hydroxy-3,5-dimethylphenyl)quinoxalin-2-yl]thiourea, and 1-[7-(3,5-dichloro-4-hydroxy-phenyl)-quinoxalin-2-yl]-3-heptyl-urea.
Patent NZ-600441-A (NZ)
Title: Hair growth and / or regrowth compositions
Inventor: WENDLING SUSAN
IPC: A61P17/00
Filed: 2010-12-13
Abstract: Disclosed herein is a hair growth and/or regrowth compositions comprising: (a) at least one pyrimidine compound selected from the group represented by formula I or II, preferably minoxidil sulfate, wherein the substituents are as defined within the specification; (b) from about 0.1 to 99% by weigh of an admixture comprising: (i) at least on acid selected from selected from the group consisting of pyruvic acid, lithium pyruvate, sodium pyruvate, potassium pyruvate, magnesium pyruvate, calcium pyruvate, zinc pyruvate, manganese pyruvate, methyl pyruvate, salts thereof, prodrugs thereof, and mixtures thereof; (ii) at least one antioxidant; and (iii) at least one fatty acid mixture or fatty acid mixture source comprising at least 7 unsaturated or saturated fatty acids selected from the group consisting of butyric acid, caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, myristoleic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidic acid, gadoleic acid, pentadecanoic acid, margaric acid, margaroleic acid, behenic acid, dihomolinoleic acid, arachidonic acid and lignoceric acid; and (c) from about 1.0% to about 5% weight of the composition of a lactic acid or lactate selected from the group consisting of lactic acid, salts of lactic acid, prodrugs of lactic acid and mixtures thereof.
Patent NZ-600771-A (NZ)
Title: Core drilling tools with external fluid pathways
Inventor: DRENTH CHRISTOPHER L
IPC: E21B25/02
Filed: 2010-12-16
Abstract: A core barrel assembly including external fluid pathways (372, 378) extending generally axially long the outer surface of the core barrel assembly. The one or more external fluid pathways can allow for increased fluid flow around a latch mechanism (128). The increased fluid flow around the latch mechanism can allow the core barrel assembly to travel faster within the drill string, can allow drilling fluid to pass by the latch mechanism when engaged.
Patent NZ-600806-A (NZ)
Title: Tubular elasticated net with inextensible weft
Inventor: REVILL STUART
IPC: A23L13/60
Filed: 2010-12-31
Abstract: A tubular elasticated net (10) used for cooking layered or rolled meat products such as cooked ham has elastic warp threads (11) and independent elastic (12) and inextensible (13) weft threads. The elastic and the non-elastic weft threads have no connection to one another between the warp threads. The inextensible threads limit the diametral expansion of the tube to the desired shape of the finished product while the elastic thread squeezes the meat during cooking.
Patent NZ-602484-A (NZ)
Title: Composite additive materials
Inventor: BRANTON PETER
IPC: A24D3/12
Filed: 2011-03-31
Abstract: 602484 The disclosure relates to an agglomerated composite materials comprising particles of at least two different additive materials and a polymer binding said additive particles together the composite material. The disclosure also relates to incorporating at least two different additive materials into a filter material, using the composite material.
Patent NZ-607461-A (NZ)
Title: Control of ectoparasites
Inventor: CRAWFORD MICHAEL J
IPC: A01N43/50
Filed: 2008-06-09
Abstract: Disclosed is a method for treating ectoparasites in a non-human mammal, the method comprising administering to the non-human mammal an effective amount of a composition consisting of 5-chloro-N-[2-[4-(2-ethoxyethyl)-2,3-dimethylphenoxy]ethyI]-6-ethyl-4-pyrimidinamine (pyrimidifen) or a salt thereof and wherein the ectoparasites are selected from Boophilus spp. Rhipicephalus spp. Dermacentor spp. Hyalomma spp. Amblyomma spp. Otobius spp. Ornithodoros spp. Damalinia spp. Bovicola spp, the order Diptera or Ctenocephalides spp (and particularly for treating ticks, cattle lice, flies and fleas), and wherein the non-human mammal is selected from the group consisting of livestock and domestic animals.
Patent NZ-613644-A (NZ)
Title: Analytical aid with hydrophilic coating containing nanoparticles with silica structure
Inventor: GREIWE PETER
IPC: C09D7/12
Filed: 2012-03-21
Abstract: Disclosed herein is an analytical aid comprising a surface that is at least partly coated with a hydrophilic coating, said hydrophilic coating containing nanoparticles with a silica structure and an average particle size ranging from 1 to 500 nm, determined according to DIN ISO 22412:2008. Additionally disclosed is a method for producing an analytical aid and sampling device containing the aforementioned analytical aid that is at least partly coated.